Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950134-07-012509
Filing Date
2007-05-29
Accepted
2007-05-29 17:16:05
Documents
2
Group Members
JOHN S CLARK IIROBERT W BUTTSSOUTHPOINT CAPITAL ADVISORS LLCSOUTHPOINT GP LLCSOUTHPOINT GP LP

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE 13G d47152sc13gza.htm SC 13G/A 97012
2 JOINT FILING AGREEMENT d47152exv99w1.htm EX-99.1 16383
  Complete submission text file 0000950134-07-012509.txt   115684
Mailing Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131
Business Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131 305-534-3383
DOR BIOPHARMA INC (Subject) CIK: 0000812796 (see all company filings)

EIN.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-39976 | Film No.: 07884475
SIC: 2834 Pharmaceutical Preparations

Mailing Address 237 PARK AVENUE SUITE 900 NEW YORK NY 10017
Business Address 237 PARK AVENUE SUITE 900 NEW YORK NY 10017 212.692.6350
Southpoint Capital Advisors LP (Filed by) CIK: 0001319998 (see all company filings)

EIN.: 200975910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A